Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Non-immune factors play a significant role in alopecia areata.

The document concludes that more research is needed to fully understand the causes of PCOS.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Model improves accuracy in predicting hair loss effects.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Ziziphus spina-christi leaf extract lowered blood sugar and protected organs in diabetic rats.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Hair papilla cells are crucial for blood vessel development in hair follicles, affecting hair growth and loss.